Abeona Therapeutics - 43 Year Stock Price History | ABEO

Historical daily share price chart and data for Abeona Therapeutics since 1980 adjusted for splits. The latest closing stock price for Abeona Therapeutics as of February 03, 2023 is 2.76.
  • The all-time high Abeona Therapeutics stock closing price was 2656249.88 on May 21, 1981.
  • The Abeona Therapeutics 52-week high stock price is 9.36, which is 239.1% above the current share price.
  • The Abeona Therapeutics 52-week low stock price is 2.34, which is 15.2% below the current share price.
  • The average Abeona Therapeutics stock price for the last 52 weeks is 4.55.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Abeona Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 2.7357 2.8600 3.1000 2.5200 2.7600 -10.39%
2022 4.9356 9.2500 9.2500 2.4000 3.0800 -63.44%
2021 36.3303 42.2500 84.7500 7.1675 8.4250 -78.54%
2020 58.1428 80.2500 102.0000 25.5000 39.2500 -51.99%
2019 122.1265 175.7500 207.7500 38.5000 81.7500 -54.20%
2018 345.4885 430.0000 536.2500 160.0000 178.5000 -54.95%
2017 237.3506 125.0000 498.7500 115.0000 396.2500 226.80%
2016 97.3688 85.5000 217.5000 52.5000 121.2500 44.35%
2015 116.2192 85.0000 245.0000 69.2500 84.0000 -2.61%
2014 396.3571 312.5000 737.5000 86.0000 86.2500 -72.40%
2013 510.8135 337.5000 750.0000 287.5000 312.5000 4.17%
2012 938.5000 1750.0000 1800.0000 275.0000 300.0000 -83.33%
2011 2512.4008 3087.5000 3237.5000 1650.0000 1800.0000 -41.94%
2010 3119.1964 4000.0000 4112.5000 2250.0000 3100.0000 -24.62%
2009 2961.3095 1125.0000 5875.0000 962.5000 4112.5000 232.32%
2008 3032.9051 4275.0000 4375.0000 1000.0000 1237.5000 -69.54%
2007 5737.4502 3625.0000 12825.0000 3000.0000 4062.5000 16.07%
2006 1666.8327 3187.5000 3687.5000 125.0000 3500.0000 7.69%
2005 11160.7143 21500.0000 21750.0000 3250.0000 3250.0000 -85.31%
2004 31038.9386 32437.5000 49687.5000 15812.5000 22125.0000 -32.44%
2003 20144.0972 11562.5000 34375.0000 10937.5000 32750.0000 249.33%
2002 16675.0992 27812.5000 35312.5000 7187.5000 9375.0000 -66.22%
2001 23348.8533 31250.0000 39062.5000 14375.0000 27750.0000 -11.20%
2000 34090.5570 10937.5000 86718.7563 10156.2500 31250.0000 150.00%
1999 15058.4387 14843.7500 25390.6250 7226.5625 12500.0000 -11.11%
1998 25520.9573 68359.3750 87890.6250 7031.2500 14062.5000 -79.43%
1997 70598.1349 97656.2500 152343.7500 25390.6250 68359.3750 -27.08%
1996 186631.0901 132812.5000 335937.5000 93750.0000 93750.0000 -29.41%
1995 65042.1627 74218.7500 140625.0000 11718.7500 132812.5000 88.89%
1994 116265.1910 148437.5000 218750.0000 54687.5000 70312.5000 -55.00%
1993 264142.7866 390625.0000 421875.0000 140625.0000 156250.0000 -54.55%
1992 442144.4390 375000.0000 718750.0000 281250.0000 343750.0000 -8.33%
1991 181602.0257 62500.0000 421875.0000 62500.0000 375000.0000 500.00%
1990 133152.1739 156250.0000 234375.0000 62500.0000 62500.0000 -55.56%
1989 414837.5496 343750.0000 578125.0000 101562.5000 140625.0000 -59.09%
1988 452569.1700 421875.0000 734375.0000 296875.0000 343750.0000 -12.00%
1987 861845.3557 859375.0000 1281250.0000 328125.0000 390625.0000 -52.83%
1986 913352.2727 875000.0000 1343750.0000 656250.0000 828125.0000 -5.36%
1985 849268.3532 718750.0000 1250000.0000 625000.0000 875000.0000 19.15%
1984 600605.2372 812500.0000 968750.0000 343750.0000 734375.0000 -11.32%
1983 1198863.6364 1843750.0000 1843750.0000 656250.0000 828125.0000 -56.56%
1982 1647727.2727 1875000.0000 2281250.0000 1250000.0000 1906250.0000 3.39%
1981 1931447.6240 1656250.0000 2656249.8750 1406250.0000 1843750.0000 11.32%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.047B $0.003B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00